Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review
Q fever, caused by Coxiella burnetii (Q fever rickettsiae), is a zoonotic disease with a natural reservoir and has been reported in many countries and regions. Its clinical presentation is non-specific and easily confused with other infectious or non-infectious diseases. Conventional diagnostic meth...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1626115/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849340443616083968 |
|---|---|
| author | Chuanhua Nie Yuan Zhu Huajuan Zhou Xinmin Zhu Shaohua Hu Xiaoli Zhao Xiaohua Zhong Fengfei Qian Miao Yu Qiuting Jiang |
| author_facet | Chuanhua Nie Yuan Zhu Huajuan Zhou Xinmin Zhu Shaohua Hu Xiaoli Zhao Xiaohua Zhong Fengfei Qian Miao Yu Qiuting Jiang |
| author_sort | Chuanhua Nie |
| collection | DOAJ |
| description | Q fever, caused by Coxiella burnetii (Q fever rickettsiae), is a zoonotic disease with a natural reservoir and has been reported in many countries and regions. Its clinical presentation is non-specific and easily confused with other infectious or non-infectious diseases. Conventional diagnostic methods, such as respiratory specimen culture, often fail to yield conclusive results, increasing the risk of misdiagnosis. This case involves a 78-year-old male patient from Zhejiang Province, China, who presented with fever as the primary complaint and developed severe pneumonia. The diagnosis of H1N1 influenza co-infection with Coxiella burnetii was confirmed by bronchoalveolar lavage fluid targeted high-throughput sequencing (tNGS). Following antiviral treatment with Maraviroc and antibiotic therapy with omadacycline tosilate (a novel tetracycline-class drug) for Coxiella burnetii infection, the patient’s clinical symptoms improved, biochemical markers normalized, and pulmonary imaging showed resolution. This case highlights the potential of tNGS to improve the detection rate of mixed infections in cases of severe pneumonia of unknown etiology. The novel tetracycline drug, such as omadacycline, has demonstrated efficacy against Q fever rickettsial pneumonia, offering a new perspective for clinical diagnosis and treatment. |
| format | Article |
| id | doaj-art-0a69e070fb6741dabdca046e7d31b9c5 |
| institution | Kabale University |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-0a69e070fb6741dabdca046e7d31b9c52025-08-20T03:43:55ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-08-011210.3389/fmed.2025.16261151626115Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature reviewChuanhua NieYuan ZhuHuajuan ZhouXinmin ZhuShaohua HuXiaoli ZhaoXiaohua ZhongFengfei QianMiao YuQiuting JiangQ fever, caused by Coxiella burnetii (Q fever rickettsiae), is a zoonotic disease with a natural reservoir and has been reported in many countries and regions. Its clinical presentation is non-specific and easily confused with other infectious or non-infectious diseases. Conventional diagnostic methods, such as respiratory specimen culture, often fail to yield conclusive results, increasing the risk of misdiagnosis. This case involves a 78-year-old male patient from Zhejiang Province, China, who presented with fever as the primary complaint and developed severe pneumonia. The diagnosis of H1N1 influenza co-infection with Coxiella burnetii was confirmed by bronchoalveolar lavage fluid targeted high-throughput sequencing (tNGS). Following antiviral treatment with Maraviroc and antibiotic therapy with omadacycline tosilate (a novel tetracycline-class drug) for Coxiella burnetii infection, the patient’s clinical symptoms improved, biochemical markers normalized, and pulmonary imaging showed resolution. This case highlights the potential of tNGS to improve the detection rate of mixed infections in cases of severe pneumonia of unknown etiology. The novel tetracycline drug, such as omadacycline, has demonstrated efficacy against Q fever rickettsial pneumonia, offering a new perspective for clinical diagnosis and treatment.https://www.frontiersin.org/articles/10.3389/fmed.2025.1626115/fullQ feverinfluenzatargeted high-throughput sequencing (tNGS)omadacyclinecase |
| spellingShingle | Chuanhua Nie Yuan Zhu Huajuan Zhou Xinmin Zhu Shaohua Hu Xiaoli Zhao Xiaohua Zhong Fengfei Qian Miao Yu Qiuting Jiang Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review Frontiers in Medicine Q fever influenza targeted high-throughput sequencing (tNGS) omadacycline case |
| title | Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review |
| title_full | Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review |
| title_fullStr | Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review |
| title_full_unstemmed | Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review |
| title_short | Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review |
| title_sort | omadacycline in the treatment of severe q fever pneumonia during an influenza epidemic a case report with literature review |
| topic | Q fever influenza targeted high-throughput sequencing (tNGS) omadacycline case |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1626115/full |
| work_keys_str_mv | AT chuanhuanie omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT yuanzhu omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT huajuanzhou omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT xinminzhu omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT shaohuahu omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT xiaolizhao omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT xiaohuazhong omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT fengfeiqian omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT miaoyu omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview AT qiutingjiang omadacyclineinthetreatmentofsevereqfeverpneumoniaduringaninfluenzaepidemicacasereportwithliteraturereview |